These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32965257)

  • 1. ; LIVER LESION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH DIFFERENT DURATION OF METHOTREXATE TREATMENT.
    Panko N; Tsiura O; Shevchenko N; Zimnytska T
    Georgian Med News; 2020; (304-305):95-99. PubMed ID: 32965257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.
    Raab A; Kallinich T; Huscher D; Foeldvari I; Weller-Heinemann F; Dressler F; Kuemmerle-Deschner JB; Klein A; Horneff G
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):41. PubMed ID: 33752685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
    Polat MC; Çelikel E; Tekin ZE; Kurt T; Kaplan MM; Güngörer V; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Öner N; Sezer S; Acar BÇ
    Eur J Pediatr; 2024 Jun; 183(6):2725-2731. PubMed ID: 38554171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
    van Dijkhuizen EH; Wulffraat NM
    Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis-a cross-sectional study.
    Wibrand C; Kyvsgaard N; Christensen AE; Herlin T
    Rheumatol Int; 2023 May; 43(5):875-880. PubMed ID: 36922416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.
    Ravelli A; Viola S; Migliavacca D; Ruperto N; Pistorio A; Martini A
    J Pediatr; 1999 Sep; 135(3):316-20. PubMed ID: 10484796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
    Yassin NA; Haroon M; Elhamshary A
    Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
    Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
    Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
    Funk RS; Chan MA; Becker ML
    Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
    Kyvsgaard N; Mikkelsen TS; Thastum M; Christensen AE; Wehner PS; Nysom K; Herlin T
    PLoS One; 2019; 14(7):e0219539. PubMed ID: 31295288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
    Giancane G; Muratore V; Marzetti V; Quilis N; Benavente BS; Bagnasco F; Alongi A; Civino A; Quartulli L; Consolaro A; Ravelli A
    Arthritis Res Ther; 2019 Jul; 21(1):168. PubMed ID: 31287015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung function in children with juvenile idiopathic arthritis: A cross-sectional analysis.
    Attanasi M; Lucantoni M; Rapino D; Petrosino MI; Marsili M; Gasparroni G; Di Filippo P; Di Pillo S; Chiarelli F; Breda L
    Pediatr Pulmonol; 2019 Aug; 54(8):1242-1249. PubMed ID: 31099485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
    Bava C; Mongelli F; Pistorio A; Bertamino M; Bracciolini G; Dalprà S; Davì S; Lanni S; Muratore V; Pederzoli S; Rosina S; Schiappapietra B; Suffia C; Varnier G; Verazza S; Giancane G; Consolaro A; Ravelli A
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):50. PubMed ID: 31345226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.
    Wallace CA; Giannini EH; Spalding SJ; Hashkes PJ; O'Neil KM; Zeft AS; Szer IS; Ringold S; Brunner HI; Schanberg LE; Sundel RP; Milojevic DS; Punaro MG; Chira P; Gottlieb BS; Higgins GC; Ilowite NT; Kimura Y; Johnson A; Huang B; Lovell DJ;
    J Rheumatol; 2014 Jun; 41(6):1163-70. PubMed ID: 24786928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.
    Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
    Arthritis Rheum; 1997 Dec; 40(12):2226-34. PubMed ID: 9416861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.